147 related articles for article (PubMed ID: 1262435)
1. Craniopharyngioma: the role of insulin in promoting postoperative growth.
Costin G; Kogut MD; Phillips LS; Daughaday WH
J Clin Endocrinol Metab; 1976 Feb; 42(2):370-9. PubMed ID: 1262435
[TBL] [Abstract][Full Text] [Related]
2. Growth in children with craniopharyngioma following surgery.
Tiulpakov AN; Mazerkina NA; Brook CG; Hindmarsh PC; Peterkova VA; Gorelyshev SK
Clin Endocrinol (Oxf); 1998 Dec; 49(6):733-8. PubMed ID: 10209560
[TBL] [Abstract][Full Text] [Related]
3. [Serum somatomedin activity in children after surgery for craniopharyngioma (authors transl)].
Martinez MJ; Chaussain JL; Schimpff RM; Donnadieu M; Roger M; Job JC
Arch Fr Pediatr; 1981 Dec; 38 Suppl 1():881-6. PubMed ID: 7332440
[TBL] [Abstract][Full Text] [Related]
4. Hyperprolactinemia is associated with increased immunoreactive somatomedin C in hypopituitarism.
Clemmons DR; Underwood LE; Ridgway EC; Kliman B; Van Wyk JJ
J Clin Endocrinol Metab; 1981 Apr; 52(4):731-5. PubMed ID: 7193685
[TBL] [Abstract][Full Text] [Related]
5. Plasma growth hormone, insulin, and glucagon responses to arginine infusion in children and adolescents with idiopathic short stature, isolated growth hormone deficiency, panhypopituitarism, and anorexia nervosa.
Sizonenko PC; Rabinovitch A; Schneider P; Paunier L; Wollheim CB; Zahnd G
Pediatr Res; 1975 Sep; 9(9):733-8. PubMed ID: 1105371
[TBL] [Abstract][Full Text] [Related]
6. Dynamics of tolbutamide, glucose, and insulin interrelationships following varying doses of intravenous tolbutamide in normal subjects.
Ganda OP; Kahn CB; Soeldner JS; Gleason RE
Diabetes; 1975 Apr; 24(4):354-67. PubMed ID: 1132601
[TBL] [Abstract][Full Text] [Related]
7. Evidence for dopaminergic stimulation of growth velocity in some hypopituitary children.
Huseman CA; Hassing JM
J Clin Endocrinol Metab; 1984 Mar; 58(3):419-25. PubMed ID: 6420440
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factors I and II, prolactin, and insulin in 19 growth hormone-deficient children with excessive, normal, or decreased longitudinal growth after operation for craniopharyngioma.
Bucher H; Zapf J; Torresani T; Prader A; Froesch ER; Illig R
N Engl J Med; 1983 Nov; 309(19):1142-6. PubMed ID: 6353237
[TBL] [Abstract][Full Text] [Related]
9. Somatomedin binding proteins in GH-deficient children with normal plasma somatomedin levels.
Cohen DA; Blethen SL
J Clin Endocrinol Metab; 1983 Mar; 56(3):461-6. PubMed ID: 6185524
[TBL] [Abstract][Full Text] [Related]
10. Metabolic and hormonal responses to a protein-glucose meal in normal infants and in marasmus and marasmic kwashiorkor.
Graham GG; Nakashima J; Thompson RG; Blizzard RM
Pediatr Res; 1976 Oct; 10(10):832-43. PubMed ID: 823521
[TBL] [Abstract][Full Text] [Related]
11. Role of insulin and glucose in the induction of hypoaminoacidemia in man: studies in normal, juvenile diabetic, and insuloma patients.
Adibi SA; Morse EL; Amin PM
J Lab Clin Med; 1975 Sep; 86(3):395-409. PubMed ID: 168278
[TBL] [Abstract][Full Text] [Related]
12. Carbohydrate metabolism and pancreatic islet-cell function in thalassemia major.
Costin G; Kogut MD; Hyman C; Ortega JA
Diabetes; 1977 Mar; 26(3):230-40. PubMed ID: 320076
[TBL] [Abstract][Full Text] [Related]
13. Prolactin and somatomedin in hypopituitary patients with "catch up" growth following operations for craniopharyngioma.
Kenny FM; Guyda HJ; Wright JC; Friesen HG
J Clin Endocrinol Metab; 1973 Feb; 36(2):378-80. PubMed ID: 4683190
[No Abstract] [Full Text] [Related]
14. Stimulation of growth hormone (GH) and somatomedin C in idiopathic GH-deficient subjects by intermittent pulsatile administration of synthetic human pancreatic tumor GH-releasing factor.
Borges JL; Blizzard RM; Evans WS; Furlanetto R; Rogol AD; Kaiser DL; Rivier J; Vale W; Thorner MO
J Clin Endocrinol Metab; 1984 Jul; 59(1):1-6. PubMed ID: 6427267
[TBL] [Abstract][Full Text] [Related]
15. Human prolactin and thyrotropin concentrations in the serums of normal and hypopituitary children before and after the administration of synthetic thyrotropin-releasing hormone.
Foley TP; Jacobs LS; Hoffman W; Daughaday WH; Blizzard RM
J Clin Invest; 1972 Aug; 51(8):2143-50. PubMed ID: 4626583
[TBL] [Abstract][Full Text] [Related]
16. Response of plasma insulin to small doses of tolbutamide in obesity and acromegaly.
Pelkonen R; Taskinen MR; Nikkilä EA
Int J Obes; 1977; 1(4):315-24. PubMed ID: 617112
[TBL] [Abstract][Full Text] [Related]
17. Outcome in children with normal growth following removal of a craniopharyngioma.
Blethen SL; Weldon VV
Am J Med Sci; 1986 Jul; 292(1):21-4. PubMed ID: 3717202
[TBL] [Abstract][Full Text] [Related]
18. [Serum immunoreactive insulin after the oral administration of single dose of tolbutamide. II. Pancreatic vein immunoreactive insulin in dogs (author's transl)].
Goto A
Nihon Naibunpi Gakkai Zasshi; 1975 Aug; 51(8):685-92. PubMed ID: 1237422
[TBL] [Abstract][Full Text] [Related]
19. Results of 1-year growth hormone (GH)-releasing hormone-(1-44) treatment on growth, somatomedin-C, and 24-hour GH secretion in six children with partial GH deficiency.
Rochiccioli PE; Tauber MT; Coude FX; Arnone M; Morre M; Uboldi F; Barbeau C
J Clin Endocrinol Metab; 1987 Aug; 65(2):268-74. PubMed ID: 3110202
[TBL] [Abstract][Full Text] [Related]
20. Somatomedin-C and growth in children with precocious puberty: a study of the effect of the level of growth hormone secretion.
Rappaport R; Prevot C; Brauner R
J Clin Endocrinol Metab; 1987 Dec; 65(6):1112-7. PubMed ID: 3680478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
